Lv1
38 积分 2024-06-25 加入
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept
5个月前
已完结
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
5个月前
已完结
Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancer
6个月前
已完结
Designing and Evaluation of a Novel IL-1RA Fusion Cytokine to Enhance the Pharmacokinetics and Receptor Affinity for Better Therapeutic Intervention in Inflammatory Disorders
6个月前
已完结
Abstract 6078: GFS202A, a novel GDF15×IL-6 bispecific antibody for the treatment of cachexia
6个月前
已关闭
Tuning insulin receptor signaling using de novo-designed agonists
6个月前
已完结
ISRIB plus bortezomib triggers paraptosis in breast cancer cells via enhanced translation and subsequent proteotoxic stress
7个月前
已完结
Proteasomes suppress anticancer drug-induced cytotoxicity by inhibiting mitochondrial protein import and promoting ROS-BNIP3-mediated mitophagy
7个月前
已完结
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
7个月前
已完结
Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease
8个月前
已完结
皖公网安备34019202002308
